Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Angiotensin-(1-7) in Obesity Hypertension
NCT03604289Phase 1Terminated
- Start
- Apr 2019
- Primary completion
- May 2023
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of angiotensin-(1-7) in hypertension (HTN) (2 arms). Primary endpoint: Change in brachial artery diameter with reactive hyperemia at 15 minutes. Started Apr 2019; status: terminated.
02
Drugs
angiotensin-(1-7)
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT03604289.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03604289.